1.Emergency bedside-echocardiography in neonatal intensive care unit
Ziyu TAO ; Lijian XIE ; Jie SHEN ; Tingting XIAO ; Yongwei ZHANG ; Rufang ZHANG ; Gang QIU ; Xiaohui GONG ; Hailan LU
Chinese Journal of Perinatal Medicine 2012;(12):727-731
Objective To evaluate the clinical value of emergency bedside-echocardiography in neonatal intensive care unit.Methods Six hundred and sixty-eight infants with cardiac pathological murmurs,cyanosis and shortness of breath were detected by emergency bedside echocardiography (Sonosite Micromax 1 portable ultrasound or Philips iE33 ultrasonic systems) during January 2007 to July 2011.The accuracy of emergency bedside-echocardiography in the diagnosis of neonatal heart diseases was evaluated according to the results of surgical exploration.Results Among 668 enrolled neonates with the mean age of (7.2±1.3) d,there were 347 males and 321 females,and 309 term infants [mean gestational age (39.1±0.6) weeks (37.0~42.1 weeks)] and 359 premature infants [mean gestational age (33.7±0.91) weeks (28.9~36.9 weeks)].Totally,507 cases were found cardiac abnormality by emergency bedside-echocardiography,including 268 cases of patent ductus arteriosus (232 premature and 36 term infants),115 congenital heart disease,99 persistent fetal circulation and 25 arrythmia.Surgeries were performed on 54 infants and invasive therapy was performed on one infant,and none of them received CT,magnetic resonance imaging or invasive examinations before operation; among which,51 surgeries successed and 4 infants died.Other 452 infants were treated with medications,392 infants recovered and discharged,26 infants did not recover,14 cases died and 20 cases left the hospital before recovery.The accuracy rate of Micromax 1 portable ultrasound in diagnosing congenital heart diseases was 94.5% (52/55),while 96.4 % (53/55) for philips iE33 ultrasonic systems.Conclusions Emergency bedside-echocardiography could provide instant and valuable information of cardiovascular system,which would be helpful in making quick clinical decisions.
2.Design and Implementation of Intelligent Question Answering System of Marine Traditional Chinese Medicine Based on Knowledge Graph
Hailan HONG ; Wenlin LI ; Tao YANG ; Yue LI ; Wenjing MEI
World Science and Technology-Modernization of Traditional Chinese Medicine 2023;25(6):1935-1941
Objective In order to solve the problem of insufficient public understanding of the information of Marine Traditional Chinese Medicine and the lack of relevant knowledge service tools of Marine Traditional Chinese Medicine,the research and development of an intelligent question-answering system for Marine Traditional Chinese Medicine have been carried out,to provide a tool for public to inquire the knowledge of Marine Traditional Chinese Medicine.Methods The knowledge base is based on the fine-sized Marine Traditional Chinese Medicine knowledge graph MMKG constructed in the early stage.Aho-Corasick,Word2Vec and other algorithms were used to obtain Marine Traditional Chinese Medicine entities.From the professional point of view,a fine-sized classification method for Marine Traditional Chinese Medicine questions was proposed,and an intelligent Marine Traditional Chinese Medicine question answering system(MMKGQA)was constructed.Results The average accuracy rate,average recall rate and average F1 value of the system were 97.93%,83.41%and 89.10%,respectively,through the question corpus test of the questionnaire survey.It shows that the system can answer the relevant questions of Marine Traditional Chinese Medicine well and has high practicability and feasibility.Conclusion This system can help common users to obtain the popular science knowledge of Marine Traditional Chinese Medicine and provide an effective knowledge service tool for the researchers of Marine Traditional Chinese Medicine to acquire relevant knowledge and help the research and development of Marine new drugs.
3.Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling.
Qipeng FAN ; Dongsheng GU ; Miao HE ; Hailan LIU ; Tao SHENG ; Guorui XIE ; Ching-Xin LI ; Xiaoli ZHANG ; Brandon WAINWRIGHT ; Arash GARROSSIAN ; Massoud GARROSSIAN ; Dale GARDNER ; Jingwu XIE
Chinese Journal of Cancer 2011;30(7):472-481
The link of hedgehog (Hh) signaling activation to human cancer and synthesis of a variety of Hh signaling inhibitors raise great expectation that inhibiting Hh signaling may be effective in human cancer treatment. Cyclopamine (Cyc), an alkaloid from the Veratrum plant, is a specific natural product inhibitor of the Hh pathway that acts by targeting smoothened (SMO) protein. However, its poor solubility, acid sensitivity, and weak potency relative to other Hh antagonists prevent the clinical development of Cyc as a therapeutic agent. Here, we report properties of cyclopamine tartrate salt (CycT) and its activities in Hh signaling-mediated cancer in vitro and in vivo. Unlike Cyc, CycT is water soluble (5-10 mg/mL). The median lethal dose (LD50) of CycT was 62.5 mg/kg body weight compared to 43.5 mg/kg for Cyc, and the plasma half-life (T1/2) of CycT was not significantly different from that of Cyc. We showed that CycT had a higher inhibitory activity for Hh signaling-dependent motor neuron differentiation than did Cyc (IC50 = 50 nmol/L for CycT vs. 300 nmol/L for Cyc). We also tested the antitumor effectiveness of these Hh inhibitors using two mouse models of basal cell carcinomas (K14cre:Ptch1(neo/neo) and K14cre:SmoM2(YFP)). After topical application of CycT or Cyc daily for 21 days, we found that all CycT-treated mice had tumor shrinkage and decreased expression of Hh target genes. Taken together, we found that CycT is an effective inhibitor of Hh signaling-mediated carcinogenesis.
Animals
;
Carcinoma, Basal Cell
;
pathology
;
Cell Differentiation
;
drug effects
;
Embryonic Stem Cells
;
cytology
;
Hedgehog Proteins
;
antagonists & inhibitors
;
metabolism
;
Mice
;
Motor Neurons
;
cytology
;
Plants, Medicinal
;
chemistry
;
Receptors, G-Protein-Coupled
;
antagonists & inhibitors
;
metabolism
;
Signal Transduction
;
drug effects
;
Skin Neoplasms
;
pathology
;
Smoothened Receptor
;
Solubility
;
Tartrates
;
blood
;
pharmacology
;
Tumor Burden
;
drug effects
;
Veratrum
;
chemistry
;
Veratrum Alkaloids
;
blood
;
isolation & purification
;
pharmacology
4.Study on the Molecular Mechanism of Shema Zhichuan Liquid in the Treatment of Neutrophilic Asthma Based on Network Pharmacology and In Vivo Experiment
Leshen LIAN ; Xingru MENG ; Xiufang HUANG ; Jinxi ZHOU ; Yanxiao XIE ; Hailan TAO ; Ziyun JIANG ; Xiaohong LIU
Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(2):247-256
Objective To investigate the molecular mechanism of Shema Zhichuan Liquid in the treatment of neutrophilic asthma(NA)based on network pharmacology and in vivo experiments.Methods(1)The TCMSP,literature search and Swiss ADME and Swiss Target Prediction databases were used to search and screen the active components and their targets of Shema Zhichuan Liquid.OMIM,GeneCards,DisGeNET and DrugBank databases were used to search and screen NA disease-related targets.The intersection of the active components and NA disease-related targets of Shema Zhichuan Liquid was obtained through the microbiology platform to obtain the potential targets of Shema Zhichuan Liquid for the treatment of NA(common targets).Cytoscape 3.8 software was used to construct the network of"Chinese medicinals-active components-potential targets".The PPI network of potential targets was established by STRING database,and the core targets were obtained by analysing the built-in Mcode plug-in.The Metascape platform was used to enrich the gene ontology(GO),Kyoto Encyclopaedia of Genes and Genomes(KEGG)pathways for the potential targets.(2)BALB/C mice were acclimatised and fed for 1 week and randomly divided into a blank group,NA model group,low-dose group(2.5 g·kg-1)and high-dose group of Shema Zhichuan Liquid(10 g·kg-1),and control group of Dexamethasone(1 mg·kg-1);the NA mouse model was replicated by intraperitoneal injection of sensitizer(OVA+CFA)and nebulized inhalation excitation.OVA/CFA(20 μg OVA+75 μg CFA,0.3 mL)was injected intraperitoneally to sensitize on days 0,7 and 14 respectively,and 5%OVA suspension was nebulized on days 21-30(8 mL each time,40 minutes each time,once a day);1 hour before nebulisation,each group was administered by gastric gavage,and the Dexamethasone control group was administered by intraperitoneal injection once a day.The pathological changes of mouse lung tissue were observed by HE staining;IL-8 content in alveolar lavage fluid was detected by ELISA;mRNA expression levels of NLRP3 and CXCR2 were detected by RT-qPCR;and p-mTOR protein expression levels was detected by immunohistochemistry.Results(1)A total of 826 active component targets and 154 NA disease-related targets were obtained,and 51 potential targets(common targets)for the treatment of NA were obtained from the intersection of the active component and the NA disease-related targets of Shema Zhichuan Liquid.Through the network analysis of"Chinese medicinals-active components-potential targets",quercetin,lignocerotoxin,kaempferol,stigmasterol,naringenin and other key active components were obtained.The PPI network analysis of potential targets yielded 29 core targets,including AKT1,IL6,TNF,EGFR,NLRP3,RELA,MIF,CXCR2,VEGFA,etc..The GO functional enrichment analysis yielded 882 biological process entries,33 cellular component entries,and 61 molecular function entries;KEGG analysis yielded 142 signaling pathways,mainly involving TNF signaling pathway,influenza A signaling pathway,Toll-like receptor pathway,MAPK signaling pathway,mTOR signaling pathway and so on.(2)Results of animal experiments:compared with the blank group,mice in the NA model group showed obvious damage to the airway mucosa,structural disorders,a large number of inflammatory cells infiltration,mucosal congestion,oedema,obvious thickening of the alveolar wall,and narrowing of the alveolar lumen;the level of the inflammatory factor IL-8 in the alveolar lavage fluid was significantly elevated(P<0.05);the mRNA expressions of NLRP3 and CXCR2 in the lung tissues of the mice were significantly up-regulated(P<0.01),and the protein expression of p-mTOR was significantly increased.Compared with the NA model group,the structural arrangement of bronchial epithelial cells in the mice in the low-and high-dose groups of Shema Zhichuan Liquid was slightly disordered,with a small amount of inflammatory cell infiltration around the airways and blood vessels,and the congestion and edema of the bronchial mucosa were significantly reduced;the mRNA expression of CXCR2 in the lung tissues of the mice was significantly down-regulated(P<0.01),and the level of expression of p-mTOR protein was significantly reduced.The IL-8 level in the vesicular lavage fluid of mice in the high-dose group was significantly reduced(P<0.05);the mRNA expression of NLRP3 in the lung tissue of mice in the low-dose group was significantly down-regulated(P<0.05).Conclusion The therapeutic effect of Shema Zhichuan Liquid on NA may be achieved through the key active components,such as quercetin,lignocerol and kaempferol,acting on the core targets,such as NLRP3 and CXCR2,and regulating the key signaling pathways,such as the TNF signaling pathway,the MAPK signaling pathway,the Toll-like signaling pathway,and the mTOR pathway.
5.Novel MSX1 variants identified in families with nonsyndromic oligodontia.
Jinglei ZHENG ; Miao YU ; Haochen LIU ; Tao CAI ; Hailan FENG ; Yang LIU ; Dong HAN
International Journal of Oral Science 2021;13(1):2-2
The goal of this study was to identify MSX1 gene variants in multiple Chinese families with nonsyndromic oligodontia and analyse the functional influence of these variants. Whole-exome sequencing (WES) and Sanger sequencing were performed to identify the causal gene variants in five families with nonsyndromic oligodontia, and a series of bioinformatics databases were used for variant confirmation and functional prediction. Phenotypic characterization of the members of these families was described, and an in vitro analysis was performed for functional evaluation. Five novel MSX1 heterozygous variants were identified: three missense variants [c.662A>C (p.Q221P), c.670C>T (p.R224C), and c.809C>T (p.S270L)], one nonsense variant [c.364G>T (p.G122*)], and one frameshift variant [c.277delG (p.A93Rfs*67)]. Preliminary in vitro studies demonstrated that the subcellular localization of MSX1 was abnormal with the p.Q221P, p.R224C, p.G122*, and p.A93Rfs*67 variants compared to the wild type. Three variants (p.Q221P, p.G122*, and p.A93Rfs*67) were classified as pathogenic or likely pathogenic, while p.S270L and p.R224C were of uncertain significance in the current data. Moreover, we summarized and analysed the MSX1-related tooth agenesis positions and found that the type and variant locus were not related to the severity of tooth loss. Our results expand the variant spectrum of nonsyndromic oligodontia and provide valuable information for genetic counselling.
Anodontia/genetics*
;
Humans
;
MSX1 Transcription Factor/genetics*
;
Pedigree
;
Whole Exome Sequencing
6.A Critical Role for γCaMKII in Decoding NMDA Signaling to Regulate AMPA Receptors in Putative Inhibitory Interneurons.
Xingzhi HE ; Yang WANG ; Guangjun ZHOU ; Jing YANG ; Jiarui LI ; Tao LI ; Hailan HU ; Huan MA
Neuroscience Bulletin 2022;38(8):916-926
CaMKII is essential for long-term potentiation (LTP), a process in which synaptic strength is increased following the acquisition of information. Among the four CaMKII isoforms, γCaMKII is the one that mediates the LTP of excitatory synapses onto inhibitory interneurons (LTPE→I). However, the molecular mechanism underlying how γCaMKII mediates LTPE→I remains unclear. Here, we show that γCaMKII is highly enriched in cultured hippocampal inhibitory interneurons and opts to be activated by higher stimulating frequencies in the 10-30 Hz range. Following stimulation, γCaMKII is translocated to the synapse and becomes co-localized with the postsynaptic protein PSD-95. Knocking down γCaMKII prevents the chemical LTP-induced phosphorylation and trafficking of AMPA receptors (AMPARs) in putative inhibitory interneurons, which are restored by overexpression of γCaMKII but not its kinase-dead form. Taken together, these data suggest that γCaMKII decodes NMDAR-mediated signaling and in turn regulates AMPARs for expressing LTP in inhibitory interneurons.
Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism*
;
Hippocampus/metabolism*
;
Interneurons/physiology*
;
Long-Term Potentiation/physiology*
;
N-Methylaspartate/metabolism*
;
Receptors, AMPA/physiology*
;
Receptors, N-Methyl-D-Aspartate/metabolism*
;
Synapses/physiology*